Rhinitis and wheezing disorders in infancy and childhood are common. 1, 2 Birth cohort studies, including our Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort, have described infants and toddlers with persistent and recurrent rhinitis. Although the majority do not have allergen sensitization in infancy, early-onset rhinitis has been associated with eczema, wheeze, and parental history of allergic disorders, suggesting that atopy might play a role in the manifestation of rhinitis. [3] [4] [5] Considerable current evidence supports bacteria-virus interactions as an important factor in lower respiratory tract infections. Respiratory syncytial virus and rhinovirus have been implicated as triggers of wheezing disorders in infants and young children and as predictors of subsequent asthma at school age. [6] [7] [8] [9] [10] It has 
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Genes from the Environment GUSTO: Growing Up in Singapore Towards healthy Outcomes OTU: Operational taxonomic unit PCoA: Principal coordinates analysis SDI: Shannon Diversity Index also been recognized that the resident microbiota of the respiratory tract plays a role as a gatekeeper that either facilitates or provides resistance to colonization by respiratory viruses. 10, 11 The presence of several potentially pathogenic bacteria, such as Moraxella catarrhalis, in the airways has been associated with asthma and wheeze development. 12, 13 Moreover, farming studies support the concept that environmental microbial exposure has a protective effect on development of allergic disease. 14, 15 This brings up the concept of the ''exposome'' in which the health status of a subject is determined by his or her environmental and lifestyle exposure.
Recently, Bosch et al 16 identified significant differences in nasal microbiome profiles in infants predisposed to upper respiratory tract infections in a longitudinal study. Despite these findings, a detailed description of the nasal microbiota in infants with respect to allergic diseases, such as rhinitis and wheezing, has not been studied longitudinally. In this study we monitored and evaluated the dynamics of the nasal microbiota in a subcohort of infants belonging to the GUSTO birth cohort over 7 time points. The subjects of this subcohort had early-onset childhood rhinitis, which was associated with parental atopy and atopic comorbidities of atopic dermatitis and wheeze. 4 Given the influential role of the microbiome in the pathogenesis of respiratory tract infections and atopic diseases, the microbiome of the infant's airways might provide insights into the contributory or inhibitory role of bacteria on the manifestations of atopy.
METHODS

Study population
This case-control study recruited a subset of infants from the GUSTO birth cohort of 1237 Singaporean newborns. 17 GUSTO is a general population birth cohort of subjects not at risk for atopy. The primary objective of the GUSTO study is to identify and evaluate the role of risk factors and determinants influencing body composition and metabolism during early development and their influence on infants' health in later childhood. Rhinitis and other atopic outcomes are included as a substudy of this cohort. Briefly, mothers were recruited antenatally, and their children were followed up with scheduled home visits at 3 weeks and 3, 6, 9, 12, and 15 months and a clinic visit at 18 months. During these 7 visits, caretakers of the subjects were administered a questionnaire on demographics, lifestyle, and symptoms of rhinitis and wheeze. Positive cases of rhinitis were then followed up by monthly telephone calls to monitor rhinitis progression until a 3-month remission period was over to minimize false-positive cases. This study was approved by the relevant institutions' ethical review boards (DSRB:B/2009/584 and CIRB:2009/1024/E). Written informed consent was obtained from parents or legal guardians of the subjects.
Seven hundred thirty-three (59.3%) of 1237 evaluable subjects (excluding dropouts and those with missing clinical data) completed follow-up until 18 months of age (Fig 1) . There were 138 subjects who fulfilled our criteria of rhinitis by age 18 months. Selection of patients with rhinitis was based on the highest number of available nasal swabs. A total of 62 (44.9%) of 138 subjects who provided at least 4 of the 7 nasal swab samples were then categorized into 2 groups: rhinitis without wheeze (n 5 28) and rhinitis with wheeze (n 5 34). Sixty control subjects without rhinitis or wheeze were selected with similar characteristics (mode of delivery, age, birth order, and day care attendance) to minimize potential selection bias. Control subjects had at least 4 nasal swabs with negative responses for rhinitis and wheeze (as defined in section below) in the first 18 months of life.
Case definitions
Rhinitis was defined as having symptoms of sneezing, runny, and/or blocked nose that lasted for at least 4 weeks in single or multiple episodes (each episode lasting at least 2 weeks). This definition was based on the Allergic Rhinitis and its Impact on Asthma guidelines. 4 Wheeze was defined as the presence of wheeze symptoms (noisy breathing with a high-pitched whistling sound heard from the chest and not the mouth). Eczema was defined as physician-diagnosed eczema in the first 18 months. At the 18-month visit, subjects were assessed by means of skin prick tests for the presence of allergic sensitization to a panel of food (milk, peanut, and egg) and house dust mite (Dermatophagoides pteronyssinus and Dermatophagoides farinae) allergens from Greer Laboratories (Lenoir, NC) and Blomia tropicalis (extract obtained from our in-house laboratory). 18 Wheal size of at least 3 mm greater than that elicited by the negative control (saline) was inferred as a positive reaction. swabs and stored in Universal Transport Medium (Copan Diagnostics, Murrieta, Calif) tubes at 2808C on the same day of collection until analysis.
Nucleic acid extraction, 16S rRNA gene amplification, and sequencing DNA was extracted with the Qiagen EZ1 DNA Extraction kit and Qiagen EZ1 Advanced XL automated purification machine (Qiagen, Hilden, Germany), according to the manufacturer's instruction. Bacterial 16S rRNA gene sequences (V3-V6) were amplified and purified, as described by Ong et al. 19 Purified amplicons were fragmented with the E220 Focused-ultrasonicator (Covaris, Woburn, Mass) to yield product of an average length of 180 bases. The Qiagen GeneRead DNA Library Prep I Kit (Qiagen) was used for library preparation. The Multiplexing Sample Preparation Oligonucleotide Kit (Illumina, San Diego, Calif) was used to label DNA sequencing libraries. Multiplexed pair-end sequencing (2 3 76-bp reads) was performed with the Illumina HiSeq Rapid platform.
16S rRNA sequencing analysis
Samples with less than 100,000 reads were removed. Reconstruction of the original amplicon (V3-V6) sequences and classification of amplicon sequences followed the workflow described in Ong et al, 19 which is based on Expectation Maximization Iterative Reconstruction of Genes from the Environment (EMIRGE). 20 EMIRGE-reconstructed sequences were trimmed to the primer-amplified section and searched by using BLAST against the complete Greengenes database (dated May 2013; greengenes/13_5/99_otus.fasta).
Hits of less than the predefined percentage identity (97% at the species level, 94.5% at the genus level, 86.5% at the family level, and 75% at the phylum level) were not considered for classification and removed. EMIRGE assigns abundance estimates to reconstructed sequences. Those quality-passed sequences were clustered into operational taxonomy units (OTUs). The relative abundance of OTUs and Shannon Diversity Index (SDI) were calculated for each sample at each taxonomic level.
Bioinformatics analysis
All bioinformatics analyses were performed in R version 3.4.1 within R studio version 1.0.136. The ''vegan'' package was used to plot rarefaction curves, and principal coordinates analysis (PCoA) based on Bray-Curtis distance was used to visualize the separation of microbiota profiles between groups. The ''Envfit'' function was used to fit bacterial abundance onto ordination space (P < .001, 999 permutations) to determine the microbial determinants that shape the bacterial community composition. 21 Sankey plots were constructed by using a custom C11 script (https://github.com/ BetaCollins/Sankey). Spearman correlation analysis was done with the CoNet plugin in Cytoscape, as described by Hannigan et al. 22, 23 The correlation heat map and network were visualized in GraphPad Prism 7.0 (GraphPad Software, La Jolla, Calif) and Cytoscape 3.4.0 software, respectively.
Statistical analysis
All statistical analyses were carried out with SPSS Statistics software (version 22; IBM, New York, NY). Univariate analysis (x 2 test) was used to study demographic, lifestyle, and clinical factors between groups. Linear mixed modeling and linear regression were used to evaluate bacterial abundance longitudinally and at specific time points, respectively, as well as to explore the effect of demographic factors on abundance of the main bacterial groups while adjusting for potential confounders. All statistical significance tests and CIs were 2-sided and set at a P value of less than .05. Geometric means were used to represent bacterial abundance and SDI because of nonparametric data distribution.
RESULTS
Demographics, lifestyle, and clinical characteristics
Demographics, lifestyle, and clinical characteristics of the population were summarized in Table I . Eczema symptoms and allergen sensitization to any of the 6 tested allergens were more common in the rhinitis than control groups (P <.05). Maternal history of eczema and paternal history of rhinitis and eczema were also more common in the rhinitis without wheeze group than the control group (P < .05). Use of postnatal antibiotics, Chinese/Malay ethnicity, maternal history of rhinitis, and infant care attendance in the first year were significantly associated with rhinitis with concomitant wheeze compared with control infants (P < .05). Other demographic and clinical factors were not significantly different between groups.
In the clinical groups with rhinitis, the mean 6 SD onset of rhinitis symptoms was 7.1 6 4.8 months (range, 3 weeks to 18 months), and wheeze symptom onset was 8.2 6 4.6 months (range, 3-18 months).
16S rRNA sequencing summary
There were 670 nasal swab samples collected from 122 subjects (62 cases and 60 control subjects). Excluding samples with low yield of DNA concentration and low read counts, this yielded 620 nasal swab samples. The sequencing summary is presented in Table E1 in this article's Online Repository at www. jacionline.org. The rarefaction curve for number of observed OTUs at the family level were generated (see Fig E1 in this article's Online Repository at www.jacionline.org).
Dynamics of bacterial diversity
Overall, SDI was significantly lower in both rhinitis groups (without wheeze: geometric mean SDI 5 0.85; with wheeze: geometric mean SDI 5 0.83) compared with the control group (geometric mean SDI 5 0.97; P 5 .03 and .01, respectively; Fig  2, A) . Diversity in control subjects increased (P 5 .019), whereas diversity in infants from both rhinitis groups decreased over time (without wheeze, P 5 .028; with wheeze, P 5 .025; Fig 2, B) .
Maturation of the nasal microbiota in the first 18 months of life
Overall distribution of the nasal microbiota down to the species level is shown by using Sankey plots (Fig 3) . The Sankey plots for each clinical group are shown in Fig E2 in this article' s Online Repository at www.jacionline.org. The abundance of predominant phyla, families, and genera are summarized in Fig 4 and Table  E2 in this article's Online Repository at www.jacionline.org. Abundance data down to the species level were not analyzed further because of low bacterial identification rate.
Phyla and family. For all the 3 clinical groups, the predominant phyla were Actinobacteria, Proteobacteria and Firmicutes, which accounted for more than 97% of the total nasal microbiota. Other minor phyla made up less than 2% of the whole bacterial community.
Higher abundance of Actinobacteria was associated with the control group compared with both rhinitis groups until the age of 18 months (without wheeze: adjusted P 5 .034; with wheeze: J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 1 adjusted P < .01). The Corynebacteriaceae family comprised 95.1% of this phylum. Correspondingly, the abundance of Corynebacteriaceae was greater in control subjects than in both rhinitis groups (without wheeze: adjusted P 5 .037; with wheeze: adjusted P < .01).
In contrast, higher abundance of the Proteobacteria phylum was observed for the rhinitis groups compared with the control group, but statistical significance was seen only for rhinitis with wheeze (adjusted P < .01). At the family level, Oxalobacteraceae and Moraxellaceae comprised 36.9% and 39.3% of this phylum, respectively. However, only Oxalobacteraceae was significantly higher in patients with rhinitis with wheeze than control subjects over time (adjusted P < .01).
The Firmicutes phylum did not show distinct trends longitudinally for all clinical groups. However, the Aerococcaceae family, which comprised 67.6% of this phylum, was higher in the rhinitis with wheeze group compared with the control group (adjusted P < .01). Staphylococcaceae made up 14.8% of the Firmicutes phylum and was significantly decreased in both rhinitis groups until 9 months (adjusted P < .05).
Genera. The Corynebacteriaceae, Aerococcaceae, Moraxellaceae, and Staphylococcaceae families were made up mainly of Corynebacterium species (82.0%), Alloiococcus species (94.3%), Moraxella species (43.7%), and Staphylococcus species (91.1%), respectively. The trends of these genera in the first 18 months were similar to their corresponding families (Fig 4, C) .
Janthinobacterium species was the only genus of the Oxalobacteraceae family that was identified with the sequencing data processing method used. However, the average relative abundance of this genus was only 0.3%.
In summary, the relative abundance of bacteria between the 3 clinical groups showed distinct trends throughout 18 months of life. Although differences in bacterial composition were observed for both groups of patients with rhinitis (with and without wheeze) compared with control subjects, differences were more marked in the rhinitis with concomitant wheeze group. Furthermore, correlation analysis showed that the Oxalobacteraceae family (Proteobacteria phylum) had direct negative interactions with the Aerococcaceae family (Firmicutes phylum) and Corynebacteriaceae family (Actinobacteria phylum) in all 3 clinical groups throughout the first 18 months. This reinforces the results of our longitudinal analysis (Fig 4) that a distinct pattern of microbial abundance of the major bacterial groups was associated with the clinical outcomes, where high abundance of Corynebacteriaceae and Staphylococcaceae and low abundance of Oxalobacteraceae and Aerococcaceae were associated with control subjects and the reverse pattern of abundance for rhinitis and wheeze (see Fig E3 in this article' s Online Repository at www. jacionline.org). There was lower abundance of the Corynebacteriaceae, which showed little fluctuation throughout the 18-month period in both rhinitis groups (with and without wheeze) compared with the control group. 
Multivariate analysis of nasal microbial community composition
PCoA was plotted at 7 time points to investigate the differences in community composition between clinical groups (Fig 5) . The 5 bacterial groups (Corynebacteriaceae, Oxalobacteraceae, Moraxellaceae, Aerococcaceae, and Staphylococcaceae families) together explained an average of 54.6% (range, 49.87% to 57.69%) of the overall variability in microbiota composition. Distinct bacterial community composition was seen between 2 groups of patients with rhinitis and control subjects at 3 weeks and 3 months. At these time points, Corynebacteriaceae and Staphylococcaceae significantly influenced the control group, whereas Oxalobacteraceae and Aerococcaceae shaped the rhinitis groups (P < .001). The clusters between groups became less distinct from 6 months onward. Moraxellaceae drove the bacterial composition of the rhinitis groups at this time point (P < .001). Microbial communities after 9 months showed an obvious shift and disappearing of distinct clusters between clinical groups. Of note, Corynebacteriaceae remained the key bacterial drivers of the bacterial community in control subjects until 12 months (P < .001).
Influence of demographic and clinical determinants on establishment of the main nasal bacterial groups
Linear regression was used to evaluate the effect of demographic and clinical factors on overall dynamic establishment of the 5 main bacterial families (see Fig E4 in this article' s Online Repository at www.jacionline.org). Cesarean delivery and male sex were associated with higher abundance of Aerococcaceae and lower abundance of Staphylococcaceae (adjusted P < .05). The presence of siblings and infant care attendance were associated with lower colonization of Corynebacteriaceae and higher carriage of Oxalobacteraceae and Moraxellaceae (adjusted P <.05). Other factors (preterm birth, use of intrapartum antibiotic prophylaxis and postnatal antibiotics, family history of atopic diseases, and exclusive breast-feeding pattern) did not show significant associations.
DISCUSSION
The longitudinal design of this study with serial sampling over 7 time points describes the dynamic changes and provides valuable snapshots of the succession of the nasal microbiota in early childhood. We observed distinct differences in microbiota profiles of infants with rhinitis, especially in those who also had concomitant wheeze in the first 18 months of life, compared with healthy control subjects. Because these differences were present from the earliest time points (3 weeks and 3 months of age) and before the onset of clinical symptoms in the majority of subjects, our findings strongly suggest a role of the nasal microbiome in the development of respiratory disease.
Nasal microbial diversity
Nasal microbial diversity increased with age in the control subjects, whereas the rhinitis groups (with or without concomitant Adjusted P values denote significant difference of bacterial relative abundance between the rhinitis and control groups by using linear mixed-model analysis and linear regression after adjusting for confounders (sex, family history of respiratory disease, presence of siblings, mode of delivery, use of intrapartum antibiotic prophylaxis, and postnatal antibiotics and breastfeeding pattern). *Significant difference at P < .05 between rhinitis with wheeze and control group at specific time point. **Significant difference at P < .05 between both rhinitis and control groups at specific time point.
J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 1
FIG 5.
PCoA based on Bray-Curtis dissimilarity between nasal microbiome profiles (family level) for the 3 clinical groups at various time points: 3 weeks (A), 3 months (B), 6 months (C), 9 months (D), 12 months (E), 15 months (F), and 18 months (G). Arrow shows directions from the origin for which clusters have significant abundances for the bacterial groups (P < .001, 999 permutations), and its length is proportional to the correlation between ordination and bacterial groups. wheeze) were reversed, with decreasing trends with age. Other cross-sectional studies in infants and young children with respiratory disorders, such as asthma, allergic rhinitis, and acute respiratory tract infection, have described similar findings. [24] [25] [26] Distinct bacterial profiles between the disease and healthy groups
The 3 dominating phyla of the infant nasal microbiome were Actinobacteria, Proteobacteria, and Firmicutes, which is consistent with other longitudinal studies in children. 13, 16 Both the rhinitis (without and with wheeze) groups had decreased abundance of the Corynebacteriaceae family (Actinobacteria phylum) compared with control subjects. Other studies have also shown reduced abundance of Corynebacteriaceae with other respiratory conditions, such as acute otitis media and wheezing. 13, 27 Of interest is the finding that Corynebacterium accolens from the human nasal mucosa releases antibacterial free fatty acid from human triacylglycerols. 28 Taken together, these findings suggest that a high abundance of Corynebacteriaceae confers protection by inhibiting other potentially pathogenic bacteria against respiratory diseases in infants.
In contrast to Corynebacteriaceae, there was greater abundance of Proteobacteria in patients with rhinitis and concomitant wheeze compared with control subjects. This observation was consistent with other studies that reported its association with wheezing respiratory disorders. 29 Although there have not been other reports of Oxalobacteraceae in association with wheeze in infants specifically, its relation to asthma in adults has been reported. 30 Our current study in infants strengthens the possibility that Oxalobacteraceae might contribute to wheezing disorders.
The evidence that Moraxella species (Moraxellaceae family) influence subsequent respiratory illness appears to vary between studies. Several studies have shown that Moraxella species were associated with an increased risk of pneumonia in children in the first 3 years of life. 31 On the other hand, it has also been shown to be a part of a commensal bacterial community in the first 2 years of life and protects against subsequent respiratory tract infection. 32 In our study there was no difference in abundance of Moraxella species between clinical groups longitudinally, but levels were was significantly increased in both rhinitis groups at the 6-month time point.
Similar to the Oxalobacteraceae family, abundance of the Aerococcaceae family (Firmicutes phylum) was significantly greater in the rhinitis and concomitant wheeze group compared with the control group. As in all clinical groups, Aerococcaceae colonization appears later in age (> _6 months) compared with Oxalobacteraceae and Corynebacteriaceae. This observation is consistent with previous reports in children studied longitudinally from 1 to 24 months of age. 32, 33 Microbials belonging to the Aerococcaceae were further identified to belong to the Alloiococcus species. Although this genus appeared to be strongly associated with rhinitis and wheeze in our study, other studies have shown the contrary in that lower abundance of Alloiococcus species during infancy was associated with higher numbers of acute respiratory tract infections. 13 Little is known of its role in early nasal microbial colonization. Alloiococcus is a gram-positive genus with only 1 known species, Alloiococcus otitidis. 34 This species is frequently detected in the outer/middle ear canal and nasopharyngeal sections of children with acute otitis media. Studies from Japan found that nasopharyngeal colonization of A otitidis is increased in otitis-prone children compared with that in non-otitis-prone children. 35, 36 This organism is also shown to induce local immune responses in the middle ear as a pathogen. 37, 38 The Staphylococcaceae family (Firmicutes phylum) differs between clinical groups longitudinally until 9 months, and its abundance was significantly greater at early time points (3 weeks and 3 months) in the control group compared with the rhinitis groups. This was strengthened by PCoA at 3 weeks and 3 months, and therefore Staphylococcaceae is a feature of early colonization in healthy subjects before its decreases in later infancy, which has been supported by other studies in healthy children aged less than 18 months. 13, 33 Although cutaneous colonization of Staphylococcus species, particularly Staphylococcus aureus, is associated with atopic eczema, 39 our longitudinal analysis did not show any association between eczema and colonization of nasal Staphylococcus species (data not shown).
Our data indicate that the succession of nasal bacteria over the first 18 months of life influences the susceptibility to wheeze. We observed that high carriage of Oxalobacteraceae and low abundance of Corynebacterium species (Corynebacteriaceae family) and Staphylococcaceae at early time points (up to 9 months) appeared to encourage the early colonization and growth of Alloiococcus species (Aerococcaceae family) at an accelerated rate in patients with wheeze compared with control subjects. Thus the initial establishment of Oxalobacteraceae rather than Corynebacterium species might be a predictive marker of transition to the subsequent increase in abundance of Alloiococcus species. Of note is the ''graded'' degree of dysbiosis between the rhinitis alone and rhinitis with concomitant wheeze groups, with the rhinitis with wheeze group showing the more extreme difference from the control group. It is tempting to speculate that larger deviation from ''normal'' microbial establishment in the airway is required to predispose to wheeze in infancy. Our findings are supported by Bosch et al, 16 who reported an accelerated maturation of microbiota in children with more than 2 respiratory tract infection episodes per year compared with control subjects with less than 2 episodes.
Determinants of establishment of nasal microbiota
This study found that male sex, presence of siblings, cesarean delivery, and infant care attendance influenced the establishment and maturation of the nasal microbiome. These factors could be the determinants for dysbiotic nasal microbiota that could predispose to rhinitis and wheeze later in life.
The presence of siblings and day care attendance was associated with lower abundance of Corynebacteriaceae and higher abundance of Oxalobacteraceae and Moraxellaceae. This interaction with other young children has also been shown to be related to frequent wheeze at age 2 years compared with children with little or no exposure. 40 An Australian study by Teo et al 13 showed significantly greater relative abundance of Moraxella species and lower relative abundances of Corynebacterium species in infants attending day care compared with those at home. A cross-sectional American study showed that infants with siblings were more likely be dominated by Moraxella species than Corynebacterium species, whereas the opposite pattern was observed in those without siblings. 41 Whether the increased exposure to respiratory tract viruses or its influence on establishment of the nasal microbiome through J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 1 interaction with other young children plays a more important role in the development of wheezing illness in early life will require further study.
Our results also showed that male sex and delivery by means of cesarean section was associated with a more ''dysbiotic'' nasal microbial profile, with greater abundance of Aerococcaceae and lower abundance of Staphylococcaceae. Although not observed in other studies, mode of delivery did affect succession of the nasal microbiome in early life. 16 A birth cohort study up to 6 months led by Bosch et al 16 showed that children born by means of cesarean section had a higher abundance of S aureus than vaginally born children, even though this trend was most prominent at the early time points.
In relation to sex, male sex has been shown to be a universal risk factor for respiratory disorders, such as rhinitis, wheeze, and asthma, in early childhood in most populations published and not confined to this cohort. 42, 43 This can arise from sex differences in lung airway anatomy and maturation. 44 The airways in male subjects have been found to be structurally narrower than female subjects, and this anatomic difference might contribute to the higher prevalence of wheezing disorders in male subjects. 45, 46 However, there are other sex-related differences that might explain the sex differences in nasal bacterial colonization that was observed in our cohort. First, the delay in pulmonary surfactant in the male compared with female fetal lung 47, 48 might contribute to the pattern of early microbial colonization. Surfactant proteins have the ability to aggregate and control the clearance of bacteria through binding and neutralization by acting as opsonin. [49] [50] [51] Second, the innate and adaptive immune responses of male infants are also weaker than female infants, and this difference might influence differential colonization of the nasal mucosa. [52] [53] [54] Our study did not show a significant effect of intrapartum antibiotic prophylaxis or postnatal antibiotics on the nasal microbiome. Other studies in infants with respiratory tract infection and acute otitis media have shown a negative association between antibiotic use and Corynebacteriaceae carriage. 16, 27 These differences between studies might be explained in part by the different collection sites of our study (anterior nares) and other studies (nasopharyngeal).
Limitations and conclusion
The limitation in this study is that the sampling area is the anterior nares. Several studies have highlighted variation in bacterial composition between different sites of the respiratory tract. [55] [56] [57] [58] Moreover, the effect of the virus was not analyzed in our study, which deserves further investigation. We were also unable to analyze all bacterial groups down to the species level. Future studies involving metagenomics sequencing might provide more precise identification of bacteria and might also provide information on viruses.
Despite these limitations, our longitudinal birth cohort with dense serial sampling supports the hypothesis that distinct profiles of the nasal microbiota in the first 18 months of life affects development of rhinitis and wheezing in later infancy. Our GUSTO follow-up data showed that 20% of infants with rhinitis continued to have rhinitis at the age 5 years, whereas control subjects remained rhinitis free (data not shown), indicating that rhinitis status at 18 months is a predictor for rhinitis status at age 5 years. Further work to verify these findings and their effect on subsequent allergic rhinitis and asthma in later childhood will provide important insight into the role of the nasal microbiome in these disorders. These are important steps toward developing novel strategies for the treatment and management of these disorders.
